30K+ germs Killed Within 5 seconds This has never been done before by
Anybody with Anything at Anytime
...in the history of the world! Learn How It's About time steps in where human intervention has failed technology Dr. Charles Gerba Ph.D.
World Renowned Microbiologist It's much bigger than covid-19 We Kill 99.999% Of
Germs Automatically
After Every Touch

MLX Main

Kills 99.999+% of harmful pathogens in 7 seconds without chemicals!

GermPass patented biotechnology prevents the spread of infectious disease and reduces hospital HAIs

Problem

54,000 people die prematurely every day due to preventable illnesses and 80% of the most common infectious diseases are spread by the hands through germ-infested public touchpoints such as door handles, restroom stalls, elevators, and ATMs

Our solution

Our product forms a sealed germ decontamination chamber around existing public touchpoints. After each touch, the chamber automatically seals allowing UVC LED light to automatically decontaminate the surface in less than 7 seconds.

Target Market

Our technology provides immediate relief to a $38b unaddressed US market for surface-based public germicidal infrastructure.

OUR STORY

0

Launched

0

Months before COVID-19

0

Germs Killed

0

Seconds

WHO IS
MICROLUMIX

The company you have never heard of today. The company you will never forget tomorrow

We launched in September of 2019 and incorporated on 1/1/2020. We tested our first working concept model two weeks before COVID-19 hit the US and we killed 1.5 million germs from a door handle in 5 seconds. Since then, we have killed more than a billion germs in testing.

It's Much Bigger Than

COVID-19

  • COVID-19
  • C. diff
  • MRSA
  • Candida Auris (C. auris)
  • Adenovirus

Touchpoint-Related

Infectious Diseases

  • Norovirus (winter flu)
  • E-coli
  • Klebsiella pneumoniae
  • Streptococcus
  • Listeria Monocytogenes

SICKNESS COSTS EVERYONE

In the US alone, absenteeism costs employers $260b annually. Healthcare-Associated Infections cost another $55b. Medical visits and hospitalizations due to preventable illnesses another $200b.

These factors alone account for $1/2 trillion and this is just within the US. We expect to reduce all these issues significantly and add billions back to the bottom line of public and privately-held organizations around the world.

Employee Absenteeism 260B
Preventable Medical Costs 200B
Hospital Associated Infections 55B
Watch the Harvard Club of New York Launch Event